Sidney A. Spector
Corporate Officer/Principal presso University of Arizona College of Medicine
Profilo
Sidney A.
Spector is currently an Associate Professor at the University of Arizona College of Medicine and the Chief Medical Officer at Proxenia Venture Partners LLC.
Previously, he held positions as the Vice President of US Medical Affairs at Novartis Gene Therapies, Inc., the Vice President at AveXis EU Ltd., and the Senior VP of Global Strategy & Medical Affairs at Brainstorm Cell Therapeutics, Inc. Dr. Spector obtained his doctorate degree from the University of California, Los Angeles and the Sackler School of Medicine.
Posizioni attive di Sidney A. Spector
| Società | Posizione | Inizio |
|---|---|---|
| University of Arizona College of Medicine | Corporate Officer/Principal | - |
Proxenia Venture Partners LLC
 Proxenia Venture Partners LLC Investment ManagersFinance Proxenia Venture Partners LLC (Proxenia Venture Partners) is a venture capital firm founded in 2016 by Menghis Bairu. The firm is headquartered in wilmington, Delaware. | Corporate Officer/Principal | - |
Precedenti posizioni note di Sidney A. Spector
| Società | Posizione | Fine |
|---|---|---|
| BRAINSTORM CELL THERAPEUTICS INC. | Direttore Tecnico/Scientifico/R&S | 01/03/2023 |
AveXis EU Ltd.
 AveXis EU Ltd. BiotechnologyHealth Technology Part of Novartis AG, AveXis EU Ltd. develops gene therapy products. The company is based in Dublin, Ireland. | Investitore di Private Equity | 01/06/2019 |
| AVEXIS INC | Corporate Officer/Principal | - |
Formazione di Sidney A. Spector
| University of California, Los Angeles | Doctorate Degree |
| Sackler School of Medicine | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| BRAINSTORM CELL THERAPEUTICS INC. | Health Technology |
| Aziende private | 3 |
|---|---|
Novartis Gene Therapies, Inc.
 Novartis Gene Therapies, Inc. BiotechnologyHealth Technology Novartis Gene Therapies, Inc. developed gene therapies for patients and families devastated by rare and life-threatening neurological genetic diseases. The firm’s robust AAV-based pipeline is used to provide advance treatments for Rett syndrome and Friedreich’s ataxia. The company was founded by John D. Harkey, Jr., David G. Genecov and John A. Carbona on March 8, 2010 and was headquartered in Bannockburn, IL. | Health Technology |
Proxenia Venture Partners LLC
Proxenia Venture Partners LLC Investment ManagersFinance Proxenia Venture Partners LLC (Proxenia Venture Partners) is a venture capital firm founded in 2016 by Menghis Bairu. The firm is headquartered in wilmington, Delaware. | Finance |
AveXis EU Ltd.
AveXis EU Ltd. BiotechnologyHealth Technology Part of Novartis AG, AveXis EU Ltd. develops gene therapy products. The company is based in Dublin, Ireland. | Health Technology |
- Borsa valori
- Insiders
- Sidney A. Spector